Fate Therapeutics Appoints Edward Dulac as Chief Financial Officer
Go back to Fate Therapeutics Appoints Edward Dulac as Chief Financial Officer| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.57 +0.05 (1.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.52 | 52 Week High | $4.76 | |||
| Open | $2.58 | 52 Week Low | $1.46 | |||
| Day High | $2.60 | P/E | N/A | |||
| Day Low | $2.48 | EPS | $-1.91 | |||
| Volume | 1,995,031 | |||||
